Everything we do is connected to helping people get the medicine they need to feel better and live well. It’s meaningful work and we’ve been doing it for over 20 years.
In the pharmacy benefit management (PBM)industry, we’re different. We’re owned by 18 not-for-profit Blue Cross and Blue Shield health plans. This allows us to control costs and empower our employees to put members first. It’s a successful combination. We have the lowest pharmacy trend in the industry and serve 28+ million members throughout the US.
In addition to core PBM services, we work closely with our clients to implement the right benefit design, clinical and specialty programs, formulary and networks. A few key products:
• NetResults™
• Specialty Drug Management
• Best in Care™
• GuidedHealth®
• Advanced Fraud, Waste and Abuse: Member and Prescriber Investigations
• Prime Analytics™
• CareCentered Contracting™Controlled Substance Management Program
Join us!
Prime is always looking for smart, purposeful people to join our team. We’re growing fast which means there are plenty of opportunities to advance and grow in your career.
At the same time, Prime supports flexibility and offers generous PTO so you can enjoy an enviable work/life balance. We’re a privately held company -big enough to make a difference and small enough for you to have an impact.
Follow Prime on LinkedIn to learn more.
In the pharmacy benefit management (PBM)industry, we’re different. We’re owned by 18 not-for-profit Blue Cross and Blue Shield health plans. This allows us to control costs and empower our employees to put members first. It’s a successful combination. We have the lowest pharmacy trend in the industry and serve 28+ million members throughout the US.
In addition to core PBM services, we work closely with our clients to implement the right benefit design, clinical and specialty programs, formulary and networks. A few key products:
• NetResults™
• Specialty Drug Management
• Best in Care™
• GuidedHealth®
• Advanced Fraud, Waste and Abuse: Member and Prescriber Investigations
• Prime Analytics™
• CareCentered Contracting™Controlled Substance Management Program
Join us!
Prime is always looking for smart, purposeful people to join our team. We’re growing fast which means there are plenty of opportunities to advance and grow in your career.
At the same time, Prime supports flexibility and offers generous PTO so you can enjoy an enviable work/life balance. We’re a privately held company -big enough to make a difference and small enough for you to have an impact.
Follow Prime on LinkedIn to learn more.
Location: United States, Minnesota, Eagan
Employees: 1001-5000
Founded date: 1987
Mentions in press and media 16
| Date | Title | Description |
| 05.08.2026 | Biweekly GLP-1 Drug Clears First Human Test via Dual Fatty Acid Engineering | By Scott McCain Published: Aug 05 2026, 9:01 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 19.05.2026 | Healthcare AI Investment Demands Accountability: Optura Secures $17.5M to Measure Real Returns | Optura secured $17.5M in Series A funding, led by Salesforce Ventures. Total capital now exceeds $25M. Its innovative ROAI platform empowers healthcare organizations to objectively measure artificial intelligence investment returns. The sec... |
| 14.05.2026 | Optura Raises $17.5M in Series A Funding | Optura, a Nashville, Tennessee-based developer of an enterprise healthcare platform for measuring return on artificial intelligence investment (ROAI™), raised $17.5m in Series A funding. The round was led by Salesforce Ventures, with partic... |
| 14.05.2026 | Optura: $17.5 Million Series A Raised To Scale Healthcare ROAI Platform | Optura announced a $17.5 million Series A round led by Salesforce Ventures, with participation from Echo Health Ventures and continued backing from Susa Ventures, Matrix Partners, and HC9 Ventures. The financing brings the company’s total f... |
| 12.09.2024 | GLP-1 drugs are a tool, not a panacea, says Tufts professor: ‘Structured lifestyle support, including food is medicine, is critical to prevent weight regain’ | GLP-1 drugs are “the most effective drugs we’ve ever invented for obesity treatment,” but they “aren’t going to cure the obesity epidemic,” says one public health expert. Speaking at a panel debate hosted by the Food is Medicine Institute a... |
| 17.08.2024 | Health | How little Denmark got homegrown giant Novo Nordisk to lower Ozempic prices | In Denmark, with prescriptions for the drugs gobbling up 18% of regional drug budgets in 2023, officials were considering the unthinkable in a system that prides itself on free cradle-to-grave coverage: forcing patients to pay out-of-pocket... |
| 10.07.2024 | Study Reveals Two-Year Adherence Rates for Ozempic: What's With Drake's BBL Drizzy Controversy? | By Joseph Henry Published Jul 10, 2024 11:34AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket A recent analysis of U.S. pharmacy claims sheds light on a concerning trend: low long... |
| 18.06.2024 | Capital Rx Appoints Antonio Garcia Cueto as Chief Financial Officer | Former Eden Health CFO & COO to lead financial strategy at rapidly growing Capital Rx NEW YORK, June 18, 2024 /PRNewswire/ -- Capital Rx, the full-service pharmacy benefit manager ('PBM') and pharmacy benefit administrator ('PBA') advan... |
| 13.03.2024 | Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance | - |
| 12.03.2024 | Readout of Biden-Harris Administration Convening with Health Care Community Concerning Cyberattack on Change Healthcare | Leaders from HHS, White House, DOL, and the health care community convened to discuss ways to mitigate harms to patient and providers caused by the cyberattack. On Tuesday, March 12, the U.S. Department of Health and Human Services (HHS) Se... |
Show more